Pantoprazole Tablet, Delayed Release
Product Images NDC 85509-1332

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Pantoprazole (NDC 85509-1332). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Phoenix Rx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (1332 3)

Pantoprazole Sodium Delayed-Release Tablets USP 20 mg, 30 tablets, prescription oral dosage form. The label includes storage instructions, dosage guidance to swallow tablets whole, and manufacturer information for Dr. Reddy's Laboratories Inc., repackaged by PHOENIX RX LLC, Hatboro, PA. NDC 85509-1332-3 is visible.*

FDA Label Image

Structure (Structure)

Chemical structure diagram of pantoprazole showing its molecular framework, including a substituted benzimidazole ring with attached functional groups, sodium ion, and water of hydration.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.